​

LeMaitre Vascular (LMAT) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

LMAT Stock Forecast

LeMaitre Vascular (LMAT) stock forecast, based on 2 Wall Street analysts, predicts a 12-month average price target of $98.00, with a high of $100.00 and a low of $96.00. This represents a -1.92% decline from the last price of $99.92.

$55 $66 $77 $88 $99 $110 High: $100 Avg: $98 Low: $96 Last Closed Price: $99.92

LMAT Stock Rating

LeMaitre Vascular stock's rating consensus is Buy, based on 2 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 1 Buy (50.00%), 1 Hold (50.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 2 0 1 1 Strong Sell Sell Hold Buy Strong Buy

LMAT Forecast vs Benchmarks

TypeNameUpside
StockLeMaitre Vascular-1.92%
SectorHealthcare Stocks 25.20%
IndustryMedical Instruments & Supplies Stocks19.92%

Price Target Trends

1M3M12M
# Anlaysts--3
Avg Price Target--$90.33
Last Closing Price$99.92$99.92$99.92
Upside/Downside---9.60%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25343--10
Dec, 24343--10
Nov, 24346--13
Oct, 24446--14
Sep, 24446--14
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 15, 2024Ross OsbornCantor Fitzgerald$96.00$92.144.19%-3.92%
Aug 20, 2024Daniel StauderJMP Securities$100.00$85.5316.92%0.08%
Apr 26, 2024Rick WiseStifel Nicolaus$75.00$65.4614.57%-24.94%
Sep 06, 2023Suraj KaliaOppenheimer$70.00$56.7123.44%-29.94%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Nov 01, 2024OppenheimerOutperformOutperformhold
Oct 15, 2024JMP SecuritiesNeutralNeutralhold
Oct 15, 2024Cantor FitzgeraldNeutralinitialise
Aug 20, 2024JMP SecuritiesOutperformOutperformhold
May 03, 2024JMP SecuritiesOutperformOutperformhold
Sep 06, 2023OppenheimerOutperforminitialise

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$1.05$1.27$0.94$1.34----
Avg Forecast$0.99$1.28$0.93$1.32$1.94$2.16$2.38$2.60
High Forecast$0.97$1.26$0.90$1.30$1.86$2.05$2.30$2.54
Low Forecast$1.01$1.31$0.95$1.33$1.96$2.27$2.55$2.65
Surprise %6.06%-0.78%1.08%1.52%----

Revenue Forecast

$100M $140M $180M $220M $260M $300M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$129.37M$154.42M$161.65M$193.48M----
Avg Forecast$127.40M$154.61M$161.70M$193.61M$220.03M$240.15M$258.75M$284.96M
High Forecast$125.44M$152.24M$158.05M$193.45M$219.77M$235.60M$258.49M$276.26M
Low Forecast$129.64M$157.33M$164.10M$194.27M$220.62M$243.71M$259.01M$290.59M
Surprise %1.55%-0.12%-0.03%-0.06%----

Net Income Forecast

$20M $32M $44M $56M $68M $80M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$21.22M$26.91M$20.64M$30.11M----
Avg Forecast$63.46M$26.23M$26.90M$30.11M$42.86M$49.79M$56.17M$58.19M
High Forecast$50.77M$20.98M$21.52M$24.08M$41.77M$45.91M$51.57M$56.95M
Low Forecast$76.16M$31.47M$32.28M$36.13M$43.95M$50.82M$57.18M$59.42M
Surprise %-66.56%2.59%-23.28%-----

LMAT Forecast FAQ

Is LeMaitre Vascular stock a buy?

LeMaitre Vascular stock has a consensus rating of Buy, based on 2 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 1 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that LeMaitre Vascular is a favorable investment for most analysts.

What is LeMaitre Vascular's price target?

LeMaitre Vascular's price target, set by 2 Wall Street analysts, averages $98 over the next 12 months. The price target range spans from $96 at the low end to $100 at the high end, suggesting a potential -1.92% change from the previous close price of $99.92.

How does LeMaitre Vascular stock forecast compare to the average forecast of its sector, industry, and investment themes?

LeMaitre Vascular stock forecast shows a -1.92% downside, underperforming the average forecast for the healthcare stocks sector (25.20%) and underperforming the medical instruments & supplies stocks industry (19.92%).

What is the breakdown of analyst ratings for LeMaitre Vascular over the past three months?

  • January 2025: 30.00% Strong Buy, 40.00% Buy, 30.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 30.00% Strong Buy, 40.00% Buy, 30.00% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 23.08% Strong Buy, 30.77% Buy, 46.15% Hold, 0% Sell, 0% Strong Sell.

What is LeMaitre Vascular’s EPS forecast?

LeMaitre Vascular's average annual EPS forecast for its fiscal year ending in December is 1.94 for 2024, a 44.78% increase from the reported $1.34 in 2023. The prediction for 2025 is $2.16, $2.38 for 2026, and $2.6 for 2027.

What is LeMaitre Vascular’s revenue forecast?

LeMaitre Vascular's average annual revenue forecast for its fiscal year ending in December is $220.03M for 2024, a 13.72% increase from the reported $193.48M in 2023. The forecast for 2025 is $240.15M, $258.75M for 2026, and $284.96M for 2027.

What is LeMaitre Vascular’s net income forecast?

For its fiscal year ending in December, LeMaitre Vascular's average annual net income forecast is $42.86M for 2024, reflecting an 42.37% increase from the reported $30.1M in 2023. The projection for 2025 is $49.79M, $56.17M for 2026, and $58.19M for 2027.